2162.HK

Keymed Biosciences Inc.

HKSEHKDEQUITY DELAYED

80.30

▲ 2.55 (3.28%)

MARKET · —

Price

Open

78.75

Prev close

77.75

Day high

83.25

Day low

77.00

Volume

2.57M

Market cap

—

P/E (TTM)

—

52W range

44.66 – 89.75

Trailing performance

Price return · vs SPY

Returnvs SPY

+2.75% +4.1%

-6.08% -9.8%

+26.36% +23.3%

+44.04% +33.0%

YTD

+51.22% +38.9%

+21.02% +1.0%

+60.76% -13.4%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

79.32

+1.24% from price

SMA 20

78.10

+2.82% from price

SMA 50

75.50

+6.36% from price

SMA 100

71.78

+11.87% from price

SMA 200

64.04

+25.39% from price

EMA 12

78.77

+1.95% from price

EMA 26

78.36

+2.48% from price

EMA 50

75.99

+5.67% from price

RSI (14)

54.5

Neutral

MACD (12,26,9)

0.41

Hist -0.30

ATR (14)

4.09

5.10% of price

Realised vol 30D

50.3%

Annualised

Bollinger upper

83.78

20, 2σ

Bollinger lower

72.42

20, 2σ

50 / 200 cross

Golden

75.50 vs 64.04

Trend bias

Above 200

+25.39%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.28

Less volatile than market

Correlation to SPY

0.07

Largely independent

Realised vol 30D

50.3%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-41.0%

Peak to trough

Max drawdown 5Y

-69.6%

Peak to trough

ATR 14

4.09

5.10% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 80.30

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

2162.HK · links out to the publisher

Comcast adds new service to internet plans as customers leave TheStreet · 3m ago As Alcohol Consumption Falls Globally, Silly Nice Says Cannabis Is Becoming Part of a New Adult Social Ritual GlobeNewswire · 4m ago MillworkSuite Launches AI Estimating and Direct-to-CAD Platform That Cuts Drafting Time in Half PR Newswire · 10m ago Stock Market Week Ahead: A Choppy Market Heads For Nvidia Earnings, Jackson Hole Investor's Business Daily · 15m ago CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%. Motley Fool · 15m ago /DISREGARD RELEASE: CLOUDSUFI/ PR Newswire · 15m ago Microsoft Has Something Nvidia Doesn’t and Here’s Why it Matters 24/7 Wall St. · 20m ago Watch WSJ’s DC Coverage Chief Ride in a Corvette on the IndyCar Track WSJ · 20m ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.